DeepMed Research

COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Joint Outcome Study Continuation for Children With Severe Factor VIII Deficiency

Completed

Conditions: Hemophilia

First Posted Date: 2009-10-23

Last Posted Date: 2019-10-31

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 11

Registration Number: NCT01000844

Primary Care Management of Community-Acquired, Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections

Completed

Conditions: Methicillin-Resistant Staphylococcus Aureus

First Posted Date: 2009-10-16

Last Posted Date: 2013-01-25

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 4518

Registration Number: NCT00996112

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Following Lipectomy to Understand Adipose Tissue Re-accumulation

Not Applicable

Completed

Conditions: Pre-menopause
Menopause

Interventions: Procedure: Femoral lipectomy

First Posted Date: 2009-10-15

Last Posted Date: 2017-01-11

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 53

Registration Number: NCT00995631

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

Mechanisms Defending Fat Mass in Humans After Lipectomy

Not Applicable

Completed

Conditions: Expanded Fat Pads
Disproportionate Shape

Interventions: Other: Standard of Care without Liposuction
Procedure: Standard of Care with Liposuction

First Posted Date: 2009-10-12

Last Posted Date: 2016-12-06

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 32

Registration Number: NCT00993213

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Family Program for Weight Gain Prevention

Not Applicable

Completed

Conditions: Overweight
Obesity

Interventions: Behavioral: Control Group
Behavioral: Family Program for the Prevention of Weight Gain

First Posted Date: 2009-10-02

Last Posted Date: 2016-02-10

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 418

Registration Number: NCT00989170

Locations: 🇺🇸
Center for Human Nutrition, Denver, Colorado, United States

Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Other: Placebo
Drug: Dutasteride

First Posted Date: 2009-09-28

Last Posted Date: 2016-05-17

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 16

Registration Number: NCT00985738

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 Diabetes

Phase 4

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Sugar Pill
Drug: Sitagliptin

First Posted Date: 2009-09-17

Last Posted Date: 2010-03-30

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 20

Registration Number: NCT00978796

Locations: 🇺🇸
Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, United States

The Effect of Protandim on Non-alcoholic Steatohepatitis

Not Applicable

Completed

Conditions: Non-Alcoholic Steatohepatitis

Interventions: Dietary Supplement: Protandim
Dietary Supplement: Placebo

First Posted Date: 2009-09-16

Last Posted Date: 2013-02-05

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 70

Registration Number: NCT00977730

Locations: 🇺🇸
University of Colorado at Denver and Health Sciences Center, Denver, Colorado, United States

Analysis of Calcium Balance in Chronic Kidney Disease

Not Applicable

Completed

Conditions: Chronic Kidney Disease

Interventions: Dietary Supplement: High calcium diet 2000 mg/day
Dietary Supplement: Low calcium diet, 800 mg/day

First Posted Date: 2009-09-10

Last Posted Date: 2012-12-05

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 16

Registration Number: NCT00974532

Locations: 🇺🇸
University of Colorado Denver Health Sciences Center, Denver, Colorado, United States

Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia

Not Applicable

Completed

Conditions: Type 1 Diabetes

Interventions: Other: Control
Other: 20% basal insulin reduction
Drug: Terbutaline

First Posted Date: 2009-09-10

Last Posted Date: 2013-10-11

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 16

Registration Number: NCT00974051

Locations: 🇺🇸
Barbara Davis Center, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy